Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus (Q33413498)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus (English)

1 reference

Europe PubMed Central

26 July 2017

author name string

J Labrador

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566710%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

L López-Corral

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566710%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

O López-Godino

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566710%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

L Vázquez

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566710%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

M Cabrero-Calvo

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566710%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

R Pérez-López

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566710%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

M Díez-Campelo

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566710%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

E Pérez-López

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566710%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

I Alberca

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566710%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

M C Del Cañizo

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566710%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

J A Pérez-Simón

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566710%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

J R González-Porras

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566710%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

D Caballero

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566710%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

0 references

publication date

24 February 2014

1 reference

Europe PubMed Central

26 July 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566710%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

49

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566710%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566710%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

684-690

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24566710%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

https://scigraph.springernature.com/pub.10.1038/bmt.2014.17

0 references

Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

The role of the endothelium in the short-term complications of hematopoietic SCT.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Rapamycin for refractory acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Transplant-associated thrombotic microangiopathy in pediatric patients treated with sirolimus and tacrolimus

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Acute kidney injury following HCT: incidence, risk factors and outcome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Cancer awareness in atypical thrombotic microangiopathies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Thrombotic microangiopathy after GVHD prophylaxis with tacrolimus/sirolimus: a call for use of consensus definition in reporting

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.17

21 January 2018

Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24566710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24566710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24566710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical hemolytic uremic syndrome: what is it, how is it diagnosed, and how is it treated?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24566710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24566710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://pubmed.ncbi.nlm.nih.gov/24566710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24566710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/24566710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33413498&oldid=1634362669"